Proceeding contribution from Lord Walton of Detchant (Crossbench) in the House of Lords on Monday, 4 February 2008. It occurred during Debate on bill on Human Fertilisation and Embryology Bill [HL].
Human Fertilisation and Embryology Bill [HL]
moved Amendment No. 5: 5: Clause 11, page 8, line 21, after ““research)”” insert ““— (a)”” The noble Lord said: My Lords, the amendments in this group were tabled by my noble friend Lord Patel, who unfortunately is unable to be here today as he is on a professional visit overseas. They were tabled on Report, but it is important to say a few words before deciding how to proceed. Research into deriving embryonic stem cell lines for treatment purposes is proceeding, and UK-based researchers are widely regarded as among the leaders in the field. There have been recent reports, for instance, of embryonic stem cells having a great potential to treat acute macular degeneration, and researchers from Moorfields hospital in London and Sheffield University are now developing embryonic stem cells in a GMP-compliant facility—meaning good manufacturing practice—to take that work to the next stage of clinical testing. The Medical Research Council, with the Department of Health, has invested £1.2 million to create laboratory facilities in which embryonic stem cells can be developed to appropriate standards for clinical application in humans. The MRC plans further investment in the development of tissue-typed embryonic stem cell lines. When we debated in this House in 2001 the regulations amending the Human Fertilisation and Embryology Act 1990, many of us, including myself, took the view that the purpose of those regulations was to amend the Act in order to allow stem cells to be used for the treatment of serious human disease. We were therefore surprised when, either in Committee or on Report, the noble Baroness, Lady Royall, suggested that the use of such cells in treatment was not allowed under the Act and that it might even require new primary legislation. However, I am grateful to the noble Lord, Lord Darzi, for the letter he sent to many of us last week in which it would appear that that interpretation may not have been entirely correct. The Government’s position has clearly changed. There appears now to be common agreement between the Government, my noble friend Lord Patel and I that the therapeutic and research use of embryo-derived stem cells in clinical trials would be regulated by the MHRA in consultation with the Human Tissue Authority and will not—and should not—be regulated by the HFEA. Indeed, the framework of EU directives and the like for that regulation is already in place. Neither I, nor the scientists, nor the Government are arguing that the HFEA will be involved in regulation beyond the use of the embryo to derive the cell lines. For those of us who wish to see the therapeutic use of this technology without the need for further legislation—that now appears to be the Government’s view—the question is whether the terms of the original licence to create or use embryos, which can only be a research licence as the Bill stands, are adequate to enable us to say, with the certainty required by research scientists, their funders and investors, that therapeutic use will be permitted. That assurance requires more than an assertion of ministerial hope or parliamentary belief—it requires legal certainty. I therefore ask the Minister to give a clear assurance that stem cell lines derived from embryos under a research licence can ultimately be used for treatment purposes once all stages of clinical research are completed. I ask also for a commitment that the translation of research into treatment will not be delayed by the need for further legislation and that a pathway for any such legislation has been agreed. I beg to move.
Secondary information
- Type
- Proceeding contribution
- Reference
- 698 c862-3
- Session
- 2007-08
- Chamber / Committee
- House of Lords chamber
- Subjects
- Disclosure of information Codes of practice Fertility Licensing Human embryo experiments Diseases Donors Human Fertilisation and Embryology Authority Ethics IVF Parents Regulation Registration of births, deaths, marriages and civil partnerships Research Stem cells
- Legislation
- Human Fertilisation and Embryology Bill (HL) 2007-08
- Link
- View this Proceeding contribution on www.publications.parliament.uk
Librarians' tools
- Timestamp
- 2023-12-16 00:08:27 +0000
- URI
- http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_442239
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_442239
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_442239